Hyperuricemia and Gout in Solid-Organ Transplant: Update in Pharmacological Management

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

(2013) Essack Mitha et al.   RHEUMATOLOGY

Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra

(2013) Pradipta Ghosh et al.   ARTHRITIS CARE & RESEARCH

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

(2012) Naomi Schlesinger et al.   ANNALS OF THE RHEUMATIC DISEASES

2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

(2011) Robert T. Keenan et al.   AMERICAN JOURNAL OF MEDICINE

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors

(2011) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Pegloticase

(2011) Katherine A. Lyseng-Williamson   DRUGS

Contemporary epidemiology of gout in the UK general population

(2011) Lucía Cea Soriano et al.   ARTHRITIS RESEARCH & THERAPY

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

(2010) A. Durrbach et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities

(2010) A. Ioan-Facsinay et al.   ANNALS OF THE RHEUMATIC DISEASES

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

(2010) R. T. Domsic et al.   ANNALS OF THE RHEUMATIC DISEASES

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

(2010) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies

(2010) S M Trifilio et al.   BONE MARROW TRANSPLANTATION

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study

(2010) L. Rostaing et al.   Clinical Journal of the American Society of Nephrology

Interactions of urate transporter URAT1 in human kidney with uricosuric drugs

(2010) HO JUNG SHIN et al.   NEPHROLOGY

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

(2010) Michael A Becker et al.   ARTHRITIS RESEARCH & THERAPY